Nicotinic Receptors, Amyloid-β, and Synaptic Failure in Alzheimer’s Disease
暂无分享,去创建一个
[1] S. Ferreira,et al. Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts , 2007, Progress in Neurobiology.
[2] J. Yakel,et al. Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by β-amyloid1–42 peptide , 2007, Journal of Molecular Neuroscience.
[3] Yongling Zhu,et al. Identification of Sequence Motifs That Target Neuronal Nicotinic Receptors to Dendrites and Axons , 2006, The Journal of Neuroscience.
[4] D. Purpura,et al. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders , 2007, Nature Reviews Neuroscience.
[5] P. Davies,et al. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.
[6] A. Nordberg,et al. Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists , 1992, Brain Research.
[7] A. Fisher. Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease , 2008, Neurotherapeutics.
[8] T. Kihara,et al. Amyloid beta-peptide preconditioning reduces glutamate-induced neurotoxicity by promoting endocytosis of NMDA receptor. , 2006, Biochemical and biophysical research communications.
[9] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[10] S. Ferreira,et al. Soluble Protein Oligomers as Emerging Toxins in Alzheimer′s and Other Amyloid Diseases , 2007 .
[11] D. Muñoz-Torrero. Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease. , 2008, Current medicinal chemistry.
[12] R. Rubey. The Cholinesterase Inhibitors , 2003, Journal of psychiatric practice.
[13] E. Perry,et al. Expression of the α3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease , 1998 .
[14] C. Herron,et al. Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo. , 2003, Journal of neurophysiology.
[15] T. Nabeshima,et al. α7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in β-amyloid infused rats , 2006, Neuropharmacology.
[16] N. Cutler,et al. Cholinesterase Inhibitors: A Therapeutic Strategy for Alzheimer Disease , 1999, The Annals of pharmacotherapy.
[17] K. Dineley. Beta-amyloid peptide--nicotinic acetylcholine receptor interaction: the two faces of health and disease. , 2007, Frontiers in bioscience : a journal and virtual library.
[18] Michael Frotscher,et al. Cholinergic innervation of the rat hippocampus as revealed by choline acetyltransferase immunocytochemistry: A combined light and electron microscopic study , 1985, The Journal of comparative neurology.
[19] A. Palmeri,et al. Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.
[20] C. B. Davis,et al. Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. , 2000, Journal of neurochemistry.
[21] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] K. Sumikawa,et al. Acute and chronic nicotine exposure differentially facilitate the induction of LTP , 1999, Brain Research.
[23] C. Finch,et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[24] E. Albuquerque,et al. Mammalian nicotinic acetylcholine receptors: from structure to function. , 2009, Physiological reviews.
[25] D. Small,et al. Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease. , 2002, Journal of Alzheimer's disease : JAD.
[26] J. David Sweatt,et al. β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes* , 2002, The Journal of Biological Chemistry.
[27] George Perry,et al. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease , 2009, Journal of neurochemistry.
[28] J. Jhamandas,et al. β-Amyloid Peptide Activates Non-α7 Nicotinic Acetylcholine Receptors in Rat Basal Forebrain Neurons , 2003 .
[29] J. Rusted,et al. A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine , 2005, Psychopharmacology.
[30] E. Bigio,et al. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers , 2008, Neurobiology of Aging.
[31] F. Eusebi,et al. Amyloid β1–42 peptide alters the gating of human and mouse α‐bungarotoxin‐sensitive nicotinic receptors , 2003, The Journal of physiology.
[32] S. Matsuyama,et al. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP. , 2003, Journal of pharmacological sciences.
[33] D. Chen,et al. Distributions of nicotinic acetylcholine receptor α7 and β2 subunits on cultured hippocampal neurons , 1999, Neuroscience.
[34] W. Klein,et al. Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers , 2009, Proceedings of the National Academy of Sciences.
[35] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[36] Y. He,et al. α4β2 nicotinic acetylcholine receptors are required for the amyloid β protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo , 2008, Brain Research Bulletin.
[37] S. Buckingham,et al. Subtype-specific actions of beta-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4) expressed in Xenopus laevis oocytes. , 2005, British journal of pharmacology.
[38] J. Sweatt,et al. beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. , 2002, The Journal of biological chemistry.
[39] W. Klein,et al. Amyloid beta oligomers induce impairment of neuronal insulin receptors , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] A. Levey. Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. J. Dougherty,et al. β-Amyloid Regulation of Presynaptic Nicotinic Receptors in Rat Hippocampus and Neocortex , 2003, The Journal of Neuroscience.
[42] T. Dunwiddie,et al. alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons. , 2002, Journal of neurophysiology.
[43] E. Marcello,et al. Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis. , 2008, European journal of pharmacology.
[44] M. Bennett,et al. The concept of long term potentiation of transmission at synapses , 2000, Progress in Neurobiology.
[45] Robert A Nichols,et al. Dopamine release in prefrontal cortex in response to beta-amyloid activation of alpha7 * nicotinic receptors. , 2007, Brain research.
[46] W. Klein,et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[47] J. Stephenson,et al. Chronic treatments with cholinoceptor drugs influence spatial learning in rats , 2005, Psychopharmacology.
[48] J. Changeux,et al. Role of Ca2+ Ions in Nicotinic Facilitation of GABA Release in Mouse Thalamus , 1997, The Journal of Neuroscience.
[49] P. Livrea,et al. Soluble β-Amyloid1-40 Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses , 2005, The Journal of Neuroscience.
[50] E K Perry,et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.
[51] R. Lukas,et al. A Novel Nicotinic Acetylcholine Receptor Subtype in Basal Forebrain Cholinergic Neurons with High Sensitivity to Amyloid Peptides , 2009, The Journal of Neuroscience.
[52] D. Ji,et al. Timing and Location of Nicotinic Activity Enhances or Depresses Hippocampal Synaptic Plasticity , 2001, Neuron.
[53] Su-Jane Wang,et al. Facilitation of glutamate release by nicotine involves the activation of a Ca2+/calmodulin signaling pathway in rat prefrontal cortex nerve terminals , 2006, Synapse.
[54] D. K. Berg,et al. β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[55] L. Juliano,et al. Amyloid-β Binds to the Extracellular Cysteine-rich Domain of Frizzled and Inhibits Wnt/β-Catenin Signaling* , 2008, Journal of Biological Chemistry.
[56] H. Eisenberg,et al. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer’s disease: histotopographical correlation with amyloid plaques and hyperphosphorylated‐tau protein , 1999, The European journal of neuroscience.
[57] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[58] Y. Kuo,et al. β-Amyloid Directly Inhibits Human α4β2-Nicotinic Acetylcholine Receptors Heterologously Expressed in Human SH-EP1 Cells* , 2004, Journal of Biological Chemistry.
[59] R. Nichols,et al. Dopamine release in prefrontal cortex in response to β-amyloid activation of α7∗ nicotinic receptors , 2007, Brain Research.
[60] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.
[61] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[62] Francesca Grassi,et al. Amyloid β1–42 peptide alters the gating of human and mouse α‐bungarotoxin‐sensitive nicotinic receptors , 2003 .
[63] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[64] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[65] J. A. Dani,et al. Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors. , 2007, Biochemical pharmacology.
[66] W. Klein,et al. Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine* , 2007, Journal of Biological Chemistry.
[67] Kathryn Ziegler-Graham,et al. Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.
[68] D. Bertrand,et al. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. , 2007, Annual review of pharmacology and toxicology.
[69] C. Mulle,et al. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[70] Piero Antuono,et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors , 2008, The Lancet Neurology.
[71] D. Selkoe,et al. The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Protein a , 1996 .
[72] R. Gray,et al. Hippocampal synaptic transmission enhanced by low concentrations of nicotine , 1996, Nature.
[73] G. Glenner,et al. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.
[74] S. Matsuyama,et al. Epibatidine Induces Long-Term Potentiation (LTP) via Activation of α4β2 Nicotinic Acetylcholine Receptors (nAChRs) In Vivo in the Intact Mouse Dentate Gyrus: Both α7 and α4β2 nAChRs Essential to Nicotinic LTP , 2003 .
[75] Hoau Yan Wang,et al. Amyloid Peptide Aβ1‐42 Binds Selectively and with Picomolar Affinity to α7 Nicotinic Acetylcholine Receptors , 2000 .
[76] J. Jhamandas,et al. Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons. , 2003, Journal of neurophysiology.
[77] A. Fine,et al. Ultrastructural Distribution of the α7 Nicotinic Acetylcholine Receptor Subunit in Rat Hippocampus , 2001, The Journal of Neuroscience.
[78] A. Nordberg,et al. Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease , 1998, Drug safety.
[79] P. Greengard,et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses , 2005, Neurobiology of Disease.
[80] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[81] A. Nordberg,et al. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease , 2003, Neuroscience.
[82] T. Nabeshima,et al. alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats. , 2006, Neuropharmacology.
[83] D. Selkoe,et al. The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. , 1996, Annals of the New York Academy of Sciences.
[84] R. Anwyl,et al. Nicotinic receptor‐mediated enhancement of long‐term potentiation involves activation of metabotropic glutamate receptors and ryanodine‐sensitive calcium stores in the dentate gyrus , 2006, The European journal of neuroscience.
[85] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[86] W. Klein,et al. Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.
[87] R. Malinow,et al. AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.
[88] J. Buxbaum,et al. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. , 2000, European journal of pharmacology.
[89] H. Ulrich,et al. Peptide Blockers of the Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Amyloid β* , 2005, Journal of Biological Chemistry.
[90] J. Yakel,et al. β-Amyloid1–42 Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice , 2001, The Journal of Neuroscience.
[91] Marcela Colombres,et al. Synaptotoxicity in Alzheimer's Disease: The Wnt Signaling Pathway as a Molecular Target , 2007, IUBMB life.
[92] J. Patrick,et al. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[93] J Patrick,et al. Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat , 1989, The Journal of comparative neurology.
[94] Jun Noguchi,et al. Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. , 2004, Learning & memory.
[95] W. Klein. Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer’s disease , 2006, Alzheimer's & Dementia.
[96] T. Soderling,et al. Regulatory mechanisms of AMPA receptors in synaptic plasticity , 2007, Nature Reviews Neuroscience.
[97] A. Nordberg. Effect of long‐term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET , 1993, Acta neurologica Scandinavica. Supplementum.
[98] John A. Dani,et al. Differential Desensitization and Distribution of Nicotinic Acetylcholine Receptor Subtypes in Midbrain Dopamine Areas , 2003, The Journal of Neuroscience.
[99] D. Price,et al. Muscarinic and nicotinic cholinergic binding sites in alzheimer's disease cerebral cortex , 1987, Brain Research.
[100] M. Swash,et al. Possible biochemical basis of memory disorder in Alzheimer disease , 1978, Annals of neurology.
[101] S. Buckingham,et al. Subtype‐specific actions of β‐amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (α7, α4β2, α3β4) expressed in Xenopus laevis oocytes , 2005 .
[102] H. Schröder,et al. Nicotinic acetylcholine receptors in Alzheimer's disease. , 1999, Journal of Alzheimer's disease : JAD.